This report contains market size and forecasts of Viral Vaccines in global, including the following market information:
Global Viral Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Viral Vaccines Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Viral Vaccines companies in 2020 (%)
The global Viral Vaccines market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Viral Vaccines Market Segment Percentages, By Type, 2020 (%)
Attenuated Vaccine
Inactivated Vaccine
Global Viral Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Viral Vaccines Market Segment Percentages, By Application, 2020 (%)
Hospital
Pharmaceutical Factory
Research Institute
Others
Global Viral Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Viral Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Viral Vaccines revenues share in global market, 2020 (%)
Key companies Viral Vaccines sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Viral Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Viral Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vaccines Overall Market Size
2.1 Global Viral Vaccines Market Size: 2021 VS 2027
2.2 Global Viral Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Viral Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Viral Vaccines Players in Global Market
3.2 Top Global Viral Vaccines Companies Ranked by Revenue
3.3 Global Viral Vaccines Revenue by Companies
3.4 Global Viral Vaccines Sales by Companies
3.5 Global Viral Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Viral Vaccines Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Viral Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Viral Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vaccines Market Size Markets, 2021 & 2027
4.1.2 Attenuated Vaccine
4.1.3 Inactivated Vaccine
4.2 By Type - Global Viral Vaccines Revenue & Forecasts
4.2.1 By Type - Global Viral Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Viral Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Viral Vaccines Revenue Market Share, 2016-2027
4.3 By Type - Global Viral Vaccines Sales & Forecasts
4.3.1 By Type - Global Viral Vaccines Sales, 2016-2021
4.3.2 By Type - Global Viral Vaccines Sales, 2022-2027
4.3.3 By Type - Global Viral Vaccines Sales Market Share, 2016-2027
4.4 By Type - Global Viral Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vaccines Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Pharmaceutical Factory
5.1.4 Research Institute
5.1.5 Others
5.2 By Application - Global Viral Vaccines Revenue & Forecasts
5.2.1 By Application - Global Viral Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Viral Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Viral Vaccines Revenue Market Share, 2016-2027
5.3 By Application - Global Viral Vaccines Sales & Forecasts
5.3.1 By Application - Global Viral Vaccines Sales, 2016-2021
5.3.2 By Application - Global Viral Vaccines Sales, 2022-2027
5.3.3 By Application - Global Viral Vaccines Sales Market Share, 2016-2027
5.4 By Application - Global Viral Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Viral Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Viral Vaccines Revenue & Forecasts
6.2.1 By Region - Global Viral Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Viral Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Viral Vaccines Revenue Market Share, 2016-2027
6.3 By Region - Global Viral Vaccines Sales & Forecasts
6.3.1 By Region - Global Viral Vaccines Sales, 2016-2021
6.3.2 By Region - Global Viral Vaccines Sales, 2022-2027
6.3.3 By Region - Global Viral Vaccines Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Viral Vaccines Revenue, 2016-2027
6.4.2 By Country - North America Viral Vaccines Sales, 2016-2027
6.4.3 US Viral Vaccines Market Size, 2016-2027
6.4.4 Canada Viral Vaccines Market Size, 2016-2027
6.4.5 Mexico Viral Vaccines Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Viral Vaccines Revenue, 2016-2027
6.5.2 By Country - Europe Viral Vaccines Sales, 2016-2027
6.5.3 Germany Viral Vaccines Market Size, 2016-2027
6.5.4 France Viral Vaccines Market Size, 2016-2027
6.5.5 U.K. Viral Vaccines Market Size, 2016-2027
6.5.6 Italy Viral Vaccines Market Size, 2016-2027
6.5.7 Russia Viral Vaccines Market Size, 2016-2027
6.5.8 Nordic Countries Viral Vaccines Market Size, 2016-2027
6.5.9 Benelux Viral Vaccines Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Viral Vaccines Revenue, 2016-2027
6.6.2 By Region - Asia Viral Vaccines Sales, 2016-2027
6.6.3 China Viral Vaccines Market Size, 2016-2027
6.6.4 Japan Viral Vaccines Market Size, 2016-2027
6.6.5 South Korea Viral Vaccines Market Size, 2016-2027
6.6.6 Southeast Asia Viral Vaccines Market Size, 2016-2027
6.6.7 India Viral Vaccines Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Viral Vaccines Revenue, 2016-2027
6.7.2 By Country - South America Viral Vaccines Sales, 2016-2027
6.7.3 Brazil Viral Vaccines Market Size, 2016-2027
6.7.4 Argentina Viral Vaccines Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Viral Vaccines Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Viral Vaccines Sales, 2016-2027
6.8.3 Turkey Viral Vaccines Market Size, 2016-2027
6.8.4 Israel Viral Vaccines Market Size, 2016-2027
6.8.5 Saudi Arabia Viral Vaccines Market Size, 2016-2027
6.8.6 UAE Viral Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Viral Vaccines Major Product Offerings
7.1.4 GSK Viral Vaccines Sales and Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Viral Vaccines Major Product Offerings
7.2.4 Merck Viral Vaccines Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Viral Vaccines Major Product Offerings
7.3.4 Novartis Viral Vaccines Sales and Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Viral Vaccines Major Product Offerings
7.4.4 Pfizer Viral Vaccines Sales and Revenue in Global (2016-2021)
7.4.5 Pfizer Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Viral Vaccines Major Product Offerings
7.5.4 Sanofi Viral Vaccines Sales and Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Viral Vaccines Major Product Offerings
7.6.4 Bayer Viral Vaccines Sales and Revenue in Global (2016-2021)
7.6.5 Bayer Key News
7.7 Zoetis
7.7.1 Zoetis Corporate Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Viral Vaccines Major Product Offerings
7.4.4 Zoetis Viral Vaccines Sales and Revenue in Global (2016-2021)
7.7.5 Zoetis Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Viral Vaccines Major Product Offerings
7.8.4 AstraZeneca Viral Vaccines Sales and Revenue in Global (2016-2021)
7.8.5 AstraZeneca Key News
7.9 Johnson
7.9.1 Johnson Corporate Summary
7.9.2 Johnson Business Overview
7.9.3 Johnson Viral Vaccines Major Product Offerings
7.9.4 Johnson Viral Vaccines Sales and Revenue in Global (2016-2021)
7.9.5 Johnson Key News
7.10 CSL
7.10.1 CSL Corporate Summary
7.10.2 CSL Business Overview
7.10.3 CSL Viral Vaccines Major Product Offerings
7.10.4 CSL Viral Vaccines Sales and Revenue in Global (2016-2021)
7.10.5 CSL Key News
8 Global Viral Vaccines Production Capacity, Analysis
8.1 Global Viral Vaccines Production Capacity, 2016-2027
8.2 Viral Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Viral Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Viral Vaccines Supply Chain Analysis
10.1 Viral Vaccines Industry Value Chain
10.2 Viral Vaccines Upstream Market
10.3 Viral Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Viral Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Viral Vaccines in Global Market
Table 2. Top Viral Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Viral Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Viral Vaccines Revenue Share by Companies, 2016-2021
Table 5. Global Viral Vaccines Sales by Companies, (K MT), 2016-2021
Table 6. Global Viral Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Viral Vaccines Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Viral Vaccines Product Type
Table 9. List of Global Tier 1 Viral Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL